Metraipolis › archive › dc_2228748ef4b0

Comparative Safety of Empirical Antibiotic Classes in Newly Hospitalized COVID-19 Patients — Europe PMC PMID:41155700

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155700
DOI
10.3390/ph18101588
License (as archived)
solo-consultazione
Archived
2026-11-09T04:34:17.942Z
SHA-256 of the archived text
775a357217bcddc9649f25d8c3b380ad93831aa0a4a58d5a718ffd1a1214b76e
Stable URL of this page
https://metraipolis.com/documento/dc_2228748ef4b0

How to cite

Comparative Safety of Empirical Antibiotic Classes in Newly Hospitalized COVID-19 Patients — Europe PMC PMID:41155700 — Europe PMC (en), https://europepmc.org/article/MED/41155700 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2228748ef4b0 (Metraipolis archive dc_2228748ef4b0, sha256 775a357217bcddc9649f25d8c3b380ad93831aa0a4a58d5a718ffd1a1214b76e)
BibTeX
@misc{dc2228748ef4b0,
  title = {Comparative Safety of Empirical Antibiotic Classes in Newly Hospitalized COVID-19 Patients — Europe PMC PMID:41155700},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155700},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2228748ef4b0; sha256 775a357217bcddc9649f25d8c3b380ad93831aa0a4a58d5a718ffd1a1214b76e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155700. Agents can read the archived copy with the MCP tool read_document.